Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 83.12

-2.1%

Jan 30 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (3218)	4/24/2015 6:36:23 PM
From: Biotech Jim	Read Replies (2) of 3722

I told my brother this morning that we should be taking RIGL profits in the $6-8 range. I bought heavily in Jan, and also held significant shares from 1-2 years back. I also bought mucho shares in my Mother's account, now distributed to all her children. The ITP studies in Ph 3 should be positive, and read out in Q1 2016. Still trying to figure out the reason for the bump after hours yesterday and continuing today. Some fund initiating a position? Or delayed reaction to the BMY collaboration? Here is a quote from that BMS/RIGL PR: "This collaboration places our TGF beta receptor kinase inhibitor program into the hands of Bristol-Myers Squibb, a premier immuno-oncology company. Together, we believe TGF beta inhibition may offer novel therapeutic opportunities in oncology treatments" http://news.bms.com/press-release/rd-news/rigel-and-bristol-myers-squibb-announce-research-and-development-collaboration

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next